Episode 235 - Why Testosterone After Breast Cancer Is Becoming a Mainstream Conversation

Ah, this was a great start to such an important episode! I literally did no planning AT ALL! I just wanted to know from Dr Jordan Emont, our guest on today’s show, if there is a common question he gets asked by his patients in his clinic.

And after getting such lovely personal insights into Jordan’s life, we ended up having an evidence-based conversation about testosterone after cancer, especially for people navigating menopause after breast cancer.

We dig into why access in the US is getting harder not easier and how clinicians think about balancing quality of life with safety when the data is still limited.

This episode is so true to all the conversations we have on this podcast because it sits right in the middle of a real-world clinical grey area: patients want relief, oncologists want reassurance, and doctors are trying to make thoughtful decisions without perfect long-term trials.

Jordan also shares how this topic is evolving in guidelines, why he thinks testosterone can help some people stay on aromatase inhibitors, and where caution still makes sense.

Episode Highlights:

00:00 Intro

09:57 Challenges in Women's Health Narratives

13:37 Differences in hormone treatments

17:25 Aromatase inhibitors in breast cancer

18:55 Discussing testosterone for cancer survivors

23:15 Testosterone use and sexual health